Resy

From WikiMD's Medical Encyclopedia

Revision as of 21:15, 20 February 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Resy is an American technology company that provides a table reservation platform for restaurants. It was founded in 2014 by Ben Leventhal, co-founder of Eater.com, and Gary Vaynerchuk, a serial entrepreneur and author. The platform allows users to discover, book, and manage reservations in some of the world’s best restaurants.

History[edit]

Resy was launched in June 2014 in New York City. The company was initially designed as a platform for buying and selling restaurant reservations. However, it quickly evolved into a comprehensive restaurant reservation and waitlist system.

In 2017, Resy acquired ClubKviar, a private dining club and restaurant booking platform based in Spain, expanding its international presence. In 2019, Resy was acquired by American Express to enhance its premium dining experiences for card members.

Features[edit]

Resy offers a variety of features for both restaurants and diners. For restaurants, Resy provides a table management system, a ticketing system for special events, a waitlist system, and a CRM system. For diners, Resy offers a mobile app that allows users to discover new restaurants, make reservations, and manage their bookings.

Reception[edit]

Resy has been well received by both restaurants and diners. Restaurants appreciate the platform's ease of use and the control it gives them over their reservations. Diners enjoy the convenience of being able to discover and book tables at a wide range of restaurants.

See also[edit]

This article is a stub related to food. You can help WikiMD by expanding it!


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.